A new season of The Progress Profile podcast turns its attention to Alzheimer’s disease, with leading researchers exploring a persistent problem: the disconnect between how clinical trials are designed and how their results are applied in everyday patient care. The series frames this as a translational challenge, where promising findings often struggle to reach clinicians and patients in practical, timely ways.
The conversations center on what it takes to close that gap. Experts examine how trial endpoints, patient selection, and outcome measures may not align with the realities of memory clinics, primary care, and long-term care settings. By bringing these perspectives together, the podcast aims to highlight both the scientific advances and the operational hurdles that shape Alzheimer’s treatment.
Because this is a single source, there are no competing viewpoints to compare. The podcast’s stated goal is to foster dialogue between research and practice, rather than to present new data or a specific breakthrough. For clinicians and researchers alike, the series offers a look at how the field is grappling with making Alzheimer’s care more responsive to evidence.